Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Consolidated net income $ 700.2 $ 748.5 $ 526.2
Adjustments to reconcile consolidated net income to net cash provided by operating activities:      
Depreciation and amortization 568.6 489.6 399.3
Stock-based compensation expense 62.6 54.9 54.7
Deferred income taxes 88.1 9.3 66.5
(Gain) Loss on fair market value adjustment and gain on sale of equity investment (36.8) 63.6 (149.5)
(Gain) on sale of asset 0.0 (4.6) 0.0
(Gain) on divestiture 0.0 (0.2) 0.0
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (138.6) (66.2) (93.7)
Other assets, current and long-term (22.4) 16.4 35.8
Current and long-term liabilities, excluding debt (464.6) 23.5 106.9
Cash provided by operating activities 757.1 1,334.8 946.2
Investing activities:      
Capital expenditures (624.5) (469.0) (421.3)
Acquisitions, net of cash acquired (433.8) (2,935.6) (61.4)
Cash received from sale of asset 0.0 4.9 0.0
Cash received from divestitures 98.8 1.5 0.0
Investment in unconsolidated affiliates, net 0.0 0.0 (10.0)
Cash used in investing activities (959.5) (3,398.2) (492.7)
Financing activities:      
Net short-term borrowings 242.2 323.4 (0.7)
Payments on long-term debt (500.0) (1,100.2) (125.0)
Proceeds from issuance of long-term debt 749.3 1,697.1 1,123.3
Treasury stock purchases 0.0 (69.9) 0.0
Dividends paid to Equifax shareholders (191.1) (190.0) (189.5)
Dividends paid to noncontrolling interests (3.1) (6.5) (4.6)
Proceeds from exercise of stock options and employee stock purchase plan 16.9 46.8 41.7
Payment of taxes related to settlement of equity awards (33.9) (57.3) (15.9)
Purchase of redeemable noncontrolling interests (0.4) (11.2) (9.0)
Debt issuance costs (6.2) (14.5) (9.8)
Other 0.0 0.0 0.3
Cash provided by financing activities 273.7 617.7 810.8
Effect of foreign currency exchange rates on cash and cash equivalents (10.8) (14.2) 19.0
Increase (decrease) in cash and cash equivalents 60.5 (1,459.9) 1,283.3
Cash and cash equivalents, beginning of period 224.7 1,684.6 401.3
Cash and cash equivalents, end of period $ 285.2 $ 224.7 $ 1,684.6